1887

Abstract

Summary

A cDNA copy of the dengue (DEN) 2 virus genome region encoding the virion capsid, membrane and envelope structural proteins has been inserted into vaccinia virus (VV) DNA under the control of its 11K late promoter. The DEN-2 envelope protein was expressed and processed in cells infected with the VV recombinant (VV/D2S). No DEN-2 virus antibody response was detected in mice, hamsters or monkeys vaccinated with VV/D2S. Furthermore, a viraemia was observed in recombinant-vaccinated monkeys after challenge with infectious DEN-2 virus.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-69-8-1921
1988-08-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/69/8/JV0690081921.html?itemId=/content/journal/jgv/10.1099/0022-1317-69-8-1921&mimeType=html&fmt=ahah

References

  1. ANGSUBHAKORN S., MOE I. B., MARCHETTE N. J., LATENDRESSE J. R., PALUMBO N. E., YOKSAN S., BHAMARAPRAVATI N. 1987; Neurovirulent detection of dengue virus using rhesus and Cynomolgus monkeys. Journal of Viwlogical Methods 18:13–24
    [Google Scholar]
  2. BALL L. A., YOUNG K. K. Y., ANDERSON K., COLLINS P. L., WERTZ G. W. 1986; Expression of the major glycoprotein G of human respiratory syncytial virus from recombinant vaccinia virus vectors. Proceedings of the National Academy of Sciences, U.S.A 83:246–250
    [Google Scholar]
  3. BANCROFT W. H., TOP F. J. JR, ECKELS K. H., ANDERSON J. H. JR, MCCOWN J. M., RUSSELL P. K. 1981; Dengue-2 vaccine: virological, immunological, and clinical responses of six yellow fever-immune recipients. Infection and Immunity 31:698–703
    [Google Scholar]
  4. BANCROFT W. H., SCOTT R. MCN., ECKELS K. H., HOKE C. H. JR, SIMMS T. E., JESRANI K. D. T., SUMMERS P. L., DUBOIS D. R., TSOULOS D., RUSSELL P. K. 1984; Dengue virus type 2 vaccine: reactogenicity and immunogenicity in soldiers. Journal of Infectious Diseases 149:1005–1010
    [Google Scholar]
  5. BERTHOLET C. R., DRILLIEN R., WLTTEK R. 1985; One hundred base pairs of 5′ flanking sequence of a vaccinia virus late gene are sufficient to temporally regulate late transcription. Proceedings of the National Academy of Sciences, U.S.A 82:2096–2100
    [Google Scholar]
  6. CATANZARO P. J., BRANDT W. E., HOGREFE W. R., RUSSELL P. K. 1974; Detection of dengue cell surface antigens by peroxidase labelled antibodies and immune cytolysis. Infection and Immunity 10:381–388
    [Google Scholar]
  7. DEUBEL V., KINNEY R. M., TRENT D. W. 1986; Nucleotide sequence and deduced amino acid sequence of the structural proteins of dengue type 2 virus, Jamaica genotype. Virology 155:365–377
    [Google Scholar]
  8. ECKELS K. H., HARRISSON V. R., SUMMERS P. L., RUSSELL P. K. 1980; Dengue 2 vaccine: preparation from a small-plaque virus clone. Infection and Immunity 27:175–180
    [Google Scholar]
  9. ESPOSITO J. J., CONDIT R., OBUESKI J. F. 1981; The preparation of orthopoxvirus DNA. Journal of Virological Methods 2:175–179
    [Google Scholar]
  10. ESPOSITO J. J., BRECHLING K., BAER G., MOSS B. 1988; Vaccinia virus recombinants expressing rabies virus glycoprotein protect against rabies. Virus Genes 1:7–21
    [Google Scholar]
  11. GENTRY M. K., HENCHAL E. A., MCCOWN J. M., BRANDT W. E., DALRYMPLE J. M. 1982; Identification of distinct determinants of dengue-2 virus using monoclonal antibodies. American Journal of Tropical Medicine and Hygiene 31:548–555
    [Google Scholar]
  12. HALSTEAD S. B. 1980; Dengue haemorrhagic fever, a public health problem and a field for research. Bulletin of the World Health Organization 58:1–21
    [Google Scholar]
  13. HALSTEAD S. B. 1981; The pathogenesis of dengue: molecular epidemiology in infectious disease. American Journal of Epidemiology 114:632–648
    [Google Scholar]
  14. HALSTEAD S. B. 1984; Selective primary health care: strategies for control of disease in the developing world. XI. Dengue. Reviews of Infectious Diseases 6:251–264
    [Google Scholar]
  15. HALSTEAD S. B., SIMASTHIEN P. 1970; Observations related to pathogenesis of dengue hemorrhagic fever. II. Antigenic and biological properties of dengue viruses and their association with disease response in the host. Yale Journal of Biological Medicine 42:265–292
    [Google Scholar]
  16. HALSTEAD S. B., MARCHETTE N. J., DIWAN A. R., PALUMBO N. E., PUTVATANA R. 1984; Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. II. Attributes of virus cloned at different dog kidney passage levels. American Journal of Tropical Medicine and Hygiene 33:666–671
    [Google Scholar]
  17. KAUFMAN B. M., SUMMERS P. L., DUBOIS D. R., ECKELS K. H. 1987; Monoclonal antibodies against dengue 2 virus E-glycoprotein protect mice against lethal dengue infection. American Journal of Tropical Medicine and Hygiene 36:427–434
    [Google Scholar]
  18. KESSLER S. W. 1975; Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A. Journal of Immunology 115:1617–1624
    [Google Scholar]
  19. MCKEE K. T. JR, BANCROFT W. H., ECKELS K. H., REDFIELD R. R., SUMMERS P. L., RUSSELL P. K. 1987; Lack of attenuation of a candidate dengue 1 vaccine (45AZ5) in human volunteers. American Journal of Tropical Medicine and Hygiene 36:435–442
    [Google Scholar]
  20. MACKETT M., SMITH G. L., MOSS B. 1984; General method for production and selection of infectious vaccinia recombinants expressing foreign genes. Journal of Virology 49:857–864
    [Google Scholar]
  21. RICE C. M., LENCHES E. M., EDDY S. R., JUNG SHIN S., SHEETS R. L., STRAUSS J. M. 1985; Nucleotide sequence of yellow fever virus: implication for flavivirus gene expression and evolution. Science 229:726–733
    [Google Scholar]
  22. RUSSELL P. K., NISALAK A., SUKHAVACHANA P., VIVONA S. 1967; A plaque reduction test for dengue virus neutralizing antibodies. Journal of Immunology 99:285–290
    [Google Scholar]
  23. SABIN A. B., SCHLESINGER R. W. 1945; Production of immunity to dengue with virus modified by propagation in mice. Science 101:640–643
    [Google Scholar]
  24. SAROV I., JOKLIK W. K. 1972; Studies on the nature and location of the capsid polypeptides of vaccinia virions. Virology 50:579–592
    [Google Scholar]
  25. SINGER R. H., BENTLEY LAWRENCE J., VILLNAVE C. 1986; Optimization of in situ hybridization using isotopic and non-isotopic detection methods. Biotechniques 4:230–249
    [Google Scholar]
  26. THEILER M., ANDERSON C. R. 1975; The relative resistance of dengue-immune monkeys to yellow fever virus. American Journal of Tropical Medicine and Hygiene 24:115–118
    [Google Scholar]
  27. WIKTOR T. J., MACFARLAN R. I., REAGAN K. J., DIETZSCHOLD B., CURTIS P. J., WUNNER W. H., KIENY M.-P., LATHE R., LECOCQ J.-P., MACKETT M., MOSS B., KOPROWSKI H. 1984; Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene. Proceedings of the National Academy of Sciences, U.S.A 81:7194–7198
    [Google Scholar]
  28. WISSEMAN C. L., SWEET B. H., ROSENZWEIG E. C., EYLAR O. R. 1963; Attenuated living type 1 dengue vaccines. American Journal of Tropical Medicine and Hygiene 12:620–623
    [Google Scholar]
  29. ZHAO B., PRINCE G., HORSWOOD R., ECKELS K., SUMMERS P., CHANOCK R., LAI C.-J. 1987; Expression of dengue virus structural proteins and nonstructural protein NS1 by a recombinant vaccinia virus. Journal of Virology 61:4019–4022
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-69-8-1921
Loading
/content/journal/jgv/10.1099/0022-1317-69-8-1921
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error